1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Williams, M.A.
Feeney, J.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
NE
FEBS Lett.
FEBLAL
0165
0014-5793
493
70
10.1016/S0014-5793(01)02276-1
11286998
The Solution Structure of the Disulphide-Linked Dimeric of the Human Trefoil Protein Tff1
2001
UK
J.Mol.Biol.
JMOBAK
0070
0022-2836
267
418
10.1006/JMBI.1997.0896
9096235
High-Resolution Solution Structure of Human Pnr-2/ Ps2: A Single Trefoil Motif Protein
1997
UK
Biochem.J.
BIJOAK
0043
0264-6021
327
117
9355742
Homodimerization and Hetero_Oligomerization of the Single Domain Trefoil Protein Pnr-2/Ps2 Through Cysteine 58
1997
UK
Biochem.J.
BIJOAK
0043
0264-6021
308
1001
8948462
Production and Comparison of Mature Single-Domain 'Trefoil' Peptides Pnr-2/Ps2 Cys58 and Pnr-2/Ps2 Ser58
1995
IX
Eur.J.Biochem.
EJBCAI
0262
0014-2956
233
847
10.1111/J.1432-1033.1995.847_3.X
8521850
NMR-Based Structural Studies of the Pnr-2/Ps2 Single Domain Trefoil Peptide. Similarities to Porcine Spasmolytic Peptide and Evidence for a Monomeric Structure
1995
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
DISULPHIDE LINK BETWEEN C58 OF BOTH SUBUNITS
6678.365
PS2 PROTEIN
2
man
polymer
PNR-2, PS2, TFF1, BREAST CANCER ESTROGEN INDUCIBLE PROTEIN, TREFOIL FACTOR FAMILY 1 PROTEIN
no
no
EAQTETCTVAPRERQNCGFPGVTPSQCANKGCCFDDTVRGVPWCFYPNTIDVPPEEECEF
EAQTETCTVAPRERQNCGFPGVTPSQCANKGCCFDDTVRGVPWCFYPNTIDVPPEEECEF
A,B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
HUMAN
EPITHELIAL
sample
MCF-7, UACL
EXTRACELLULAR
TFF1
9606
BREAST, STOMACH
HOMO SAPIENS
CYTOPLASM
TFF1
634468
ESCHERICHIA COLI HB101
PHARMACIA PEZZ18
PLASMID
pdbx_nmr_representative
entity_src_gen
repository
Initial release
Version format compliance
Version format compliance
Structure summary
Data collection
Source and taxonomy
1
0
2001-01-03
1
1
2011-05-08
1
2
2011-07-13
1
3
2017-06-14
1
4
2019-04-10
_pdbx_nmr_representative.conformer_id
_entity_src_gen.pdbx_host_org_cell_line
_entity_src_gen.pdbx_host_org_ncbi_taxonomy_id
_entity_src_gen.pdbx_host_org_scientific_name
HIGH RESOLUTION NMR SOLUTION STRUCTURE OF HUMAN PS2, 19 STRUCTURES
PDBE
Y
PDBE
2001-01-03
REL
1PS2 SWS P04155 1 - 24 NOT IN ATOMS LIST
THE STRUCTURE WAS DETERMINED USING TWO AND THREE DIMENSIONAL NMR EXPERIMENTS ON, RESPECTIVELY, UNLABELLED AND N-15 LABELLED TFF1 DIMER PROTEIN. MANY ASSIGN WERE MADE BY MAKING USE IF THE BETTER RESOLVED MONOMER SPECTRA (POLSHAKOV ET AL. 1995,1997)
TOTAL NOE CONSTRAINT VIOLATIONS < 1.0 A
11
10
2-D 1H-1H HOMONUCLEAR TOCSY
ROESY
NOESY
1H/15N HSQC
HSQC-NOESY
0.01
5.9
pH
1
atm
298
K
REFINEMENT DETAILS CAN BE FOUND IN THE JRNL CITATION ABOVE
simulated annealing
6
BRUNGER
refinement
CNS
1.0
structure solution
CNS
1.0
500
Varian
UNITY
600
Varian
UNITYPLUS
GLU
1
n
1
GLU
1
A
ALA
2
n
2
ALA
2
A
GLN
3
n
3
GLN
3
A
THR
4
n
4
THR
4
A
GLU
5
n
5
GLU
5
A
THR
6
n
6
THR
6
A
CYS
7
n
7
CYS
7
A
THR
8
n
8
THR
8
A
VAL
9
n
9
VAL
9
A
ALA
10
n
10
ALA
10
A
PRO
11
n
11
PRO
11
A
ARG
12
n
12
ARG
12
A
GLU
13
n
13
GLU
13
A
ARG
14
n
14
ARG
14
A
GLN
15
n
15
GLN
15
A
ASN
16
n
16
ASN
16
A
CYS
17
n
17
CYS
17
A
GLY
18
n
18
GLY
18
A
PHE
19
n
19
PHE
19
A
PRO
20
n
20
PRO
20
A
GLY
21
n
21
GLY
21
A
VAL
22
n
22
VAL
22
A
THR
23
n
23
THR
23
A
PRO
24
n
24
PRO
24
A
SER
25
n
25
SER
25
A
GLN
26
n
26
GLN
26
A
CYS
27
n
27
CYS
27
A
ALA
28
n
28
ALA
28
A
ASN
29
n
29
ASN
29
A
LYS
30
n
30
LYS
30
A
GLY
31
n
31
GLY
31
A
CYS
32
n
32
CYS
32
A
CYS
33
n
33
CYS
33
A
PHE
34
n
34
PHE
34
A
ASP
35
n
35
ASP
35
A
ASP
36
n
36
ASP
36
A
THR
37
n
37
THR
37
A
VAL
38
n
38
VAL
38
A
ARG
39
n
39
ARG
39
A
GLY
40
n
40
GLY
40
A
VAL
41
n
41
VAL
41
A
PRO
42
n
42
PRO
42
A
TRP
43
n
43
TRP
43
A
CYS
44
n
44
CYS
44
A
PHE
45
n
45
PHE
45
A
TYR
46
n
46
TYR
46
A
PRO
47
n
47
PRO
47
A
ASN
48
n
48
ASN
48
A
THR
49
n
49
THR
49
A
ILE
50
n
50
ILE
50
A
ASP
51
n
51
ASP
51
A
VAL
52
n
52
VAL
52
A
PRO
53
n
53
PRO
53
A
PRO
54
n
54
PRO
54
A
GLU
55
n
55
GLU
55
A
GLU
56
n
56
GLU
56
A
GLU
57
n
57
GLU
57
A
CYS
58
n
58
CYS
58
A
GLU
59
n
59
GLU
59
A
PHE
60
n
60
PHE
60
A
GLU
1
n
1
GLU
1
B
ALA
2
n
2
ALA
2
B
GLN
3
n
3
GLN
3
B
THR
4
n
4
THR
4
B
GLU
5
n
5
GLU
5
B
THR
6
n
6
THR
6
B
CYS
7
n
7
CYS
7
B
THR
8
n
8
THR
8
B
VAL
9
n
9
VAL
9
B
ALA
10
n
10
ALA
10
B
PRO
11
n
11
PRO
11
B
ARG
12
n
12
ARG
12
B
GLU
13
n
13
GLU
13
B
ARG
14
n
14
ARG
14
B
GLN
15
n
15
GLN
15
B
ASN
16
n
16
ASN
16
B
CYS
17
n
17
CYS
17
B
GLY
18
n
18
GLY
18
B
PHE
19
n
19
PHE
19
B
PRO
20
n
20
PRO
20
B
GLY
21
n
21
GLY
21
B
VAL
22
n
22
VAL
22
B
THR
23
n
23
THR
23
B
PRO
24
n
24
PRO
24
B
SER
25
n
25
SER
25
B
GLN
26
n
26
GLN
26
B
CYS
27
n
27
CYS
27
B
ALA
28
n
28
ALA
28
B
ASN
29
n
29
ASN
29
B
LYS
30
n
30
LYS
30
B
GLY
31
n
31
GLY
31
B
CYS
32
n
32
CYS
32
B
CYS
33
n
33
CYS
33
B
PHE
34
n
34
PHE
34
B
ASP
35
n
35
ASP
35
B
ASP
36
n
36
ASP
36
B
THR
37
n
37
THR
37
B
VAL
38
n
38
VAL
38
B
ARG
39
n
39
ARG
39
B
GLY
40
n
40
GLY
40
B
VAL
41
n
41
VAL
41
B
PRO
42
n
42
PRO
42
B
TRP
43
n
43
TRP
43
B
CYS
44
n
44
CYS
44
B
PHE
45
n
45
PHE
45
B
TYR
46
n
46
TYR
46
B
PRO
47
n
47
PRO
47
B
ASN
48
n
48
ASN
48
B
THR
49
n
49
THR
49
B
ILE
50
n
50
ILE
50
B
ASP
51
n
51
ASP
51
B
VAL
52
n
52
VAL
52
B
PRO
53
n
53
PRO
53
B
PRO
54
n
54
PRO
54
B
GLU
55
n
55
GLU
55
B
GLU
56
n
56
GLU
56
B
GLU
57
n
57
GLU
57
B
CYS
58
n
58
CYS
58
B
GLU
59
n
59
GLU
59
B
PHE
60
n
60
PHE
60
B
author_defined_assembly
2
dimeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
N
THR
6
A
N
THR
6
A
O
ASN
48
A
O
ASN
48
A
N
CYS
33
A
N
CYS
33
A
O
PHE
45
A
O
PHE
45
B
N
THR
6
B
N
THR
6
B
O
ASN
48
B
O
ASN
48
B
N
CYS
33
B
N
CYS
33
B
O
PHE
45
B
O
PHE
45
1
B
B
HG1
HB
THR
ILE
4
50
1.25
1
B
B
HB
HD2
THR
PRO
23
24
1.27
1
B
B
HG23
H
THR
CYS
6
7
1.28
1
B
B
HB2
HD2
PRO
PRO
53
54
1.30
1
A
A
HG23
H
THR
THR
6
8
1.32
1
B
B
HA
OG1
THR
THR
6
49
1.53
1
B
B
HG1
O
THR
ILE
4
50
1.59
1
B
B
O
HG22
GLU
THR
5
49
1.59
1
B
B
O
ND2
THR
ASN
6
48
2.02
1
B
B
OG1
O
THR
ILE
4
50
2.12
2
A
A
H
HD3
VAL
PRO
52
53
1.12
2
A
A
HG23
H
THR
THR
6
8
1.23
2
B
B
HG3
H
GLU
GLU
56
57
1.26
2
A
A
HB
HD2
THR
PRO
23
24
1.26
2
A
A
HG2
H
GLU
CYS
57
58
1.27
2
B
B
HD2
H
PHE
GLY
19
21
1.34
3
B
B
HB3
HE22
GLU
GLN
1
3
1.31
3
A
A
HZ
HE22
PHE
GLN
19
26
1.33
3
A
A
HB
HD2
THR
PRO
23
24
1.34
3
A
A
HD22
O
ASN
GLY
16
18
1.58
4
B
B
HG21
H
THR
THR
6
8
1.25
4
B
B
HG21
HD22
VAL
ASN
9
48
1.27
4
A
A
HD2
HD3
PRO
PRO
53
54
1.27
4
A
A
HH11
HG2
ARG
GLU
12
13
1.31
4
B
B
HG3
H
GLU
CYS
57
58
1.34
5
B
B
HA
H
THR
ILE
4
50
1.05
5
B
B
H
HB
GLN
ILE
3
50
1.19
5
A
A
HG1
HG23
THR
THR
6
8
1.26
5
A
A
H
HB2
THR
GLN
23
26
1.27
5
B
B
HB2
HD3
ALA
PRO
2
53
1.31
5
B
B
H
H
THR
ASN
6
48
1.31
5
A
A
HG23
HD22
VAL
ASN
9
48
1.33
5
B
B
HD22
H
ASN
GLY
16
18
1.33
5
B
B
HH22
HG23
ARG
VAL
14
38
1.34
5
B
B
HD21
N
ASN
CYS
16
17
1.48
5
B
B
ND2
H
ASN
GLY
16
18
1.51
5
A
A
OD1
H
ASN
GLY
16
18
1.56
5
B
B
O
H
ALA
ARG
10
14
1.59
5
B
B
O
O
THR
ASN
4
48
2.00
5
B
B
O
N
GLN
ILE
3
50
2.13
5
A
A
OE1
OE1
GLU
GLN
1
3
2.17
6
B
B
H
HD3
VAL
PRO
52
53
1.22
6
A
A
HG1
HE21
THR
GLN
23
26
1.24
6
B
B
HG13
H
VAL
ALA
9
10
1.33
6
B
B
HG21
HD22
VAL
ASN
9
48
1.34
6
B
B
HG2
H
GLU
CYS
57
58
1.35
6
B
B
HE22
HB3
GLN
ASP
3
51
1.35
6
A
A
OD1
H
ASN
GLY
16
18
1.51
6
B
B
O
H
CYS
LYS
27
30
1.59
6
B
B
NE2
OD1
GLN
ASP
3
51
2.09
6
A
A
OD1
OG1
ASP
THR
35
37
2.18
7
A
A
HG21
H
THR
THR
6
8
1.21
7
A
A
HG23
HD22
VAL
ASN
9
48
1.25
7
B
B
HB
HD2
THR
PRO
23
24
1.25
7
B
B
H
HE22
ALA
GLN
2
3
1.27
7
B
B
HD21
N
ASN
CYS
16
17
1.50
7
A
A
N
O
GLY
CYS
18
44
2.18
8
B
B
H
HE21
THR
GLN
23
26
1.17
8
A
A
HG3
HD12
GLU
ILE
5
50
1.26
8
B
B
HD22
H
ASN
GLY
16
18
1.31
8
B
B
HG21
H
THR
THR
6
8
1.31
8
B
B
HD21
N
ASN
CYS
16
17
1.49
8
B
B
ND2
H
ASN
GLY
16
18
1.52
8
B
B
O
H
GLN
ASN
26
29
1.53
8
B
B
O
HZ1
GLN
LYS
26
30
1.55
9
A
A
HB2
HD2
PHE
PRO
19
20
1.18
9
B
B
HG21
H
THR
THR
6
8
1.24
9
A
A
H1
HB3
GLU
PRO
1
53
1.29
9
A
A
HA
HE22
GLU
GLN
1
3
1.34
9
A
A
HG23
HD22
VAL
ASN
9
48
1.35
9
B
B
OD1
H
ASN
GLY
16
18
1.49
9
A
A
OD1
H
ASN
GLY
16
18
1.55
10
A
A
HE21
HA
GLN
ASP
3
51
1.13
10
A
A
HB3
HA
GLN
ASP
3
51
1.29
10
A
A
H
HD3
VAL
PRO
52
53
1.30
10
B
B
H
HD3
VAL
PRO
52
53
1.30
10
B
B
HB2
HD2
PHE
PRO
19
20
1.31
10
B
B
HB
HD2
THR
PRO
23
24
1.31
10
A
A
OD1
H
ASN
GLY
16
18
1.51
1
A
PHE
19
-44.88
163.88
1
A
PRO
47
-71.68
-161.63
1
A
GLU
55
-169.95
-19.77
1
A
GLU
56
-165.66
-29.52
1
A
GLU
57
-150.78
-139.64
1
B
ALA
2
-115.48
-132.84
1
B
THR
4
-138.34
-158.42
1
B
GLU
5
-48.30
-174.23
1
B
ASN
16
-35.38
150.04
1
B
ASP
35
-170.20
79.94
1
B
ASP
36
-90.02
30.41
1
B
ASN
48
-150.24
78.52
1
B
PRO
53
-69.80
-169.17
1
B
GLU
57
-132.56
-123.45
2
A
ALA
2
-106.10
-128.51
2
A
ASN
16
-24.98
148.85
2
A
VAL
22
-39.90
163.24
2
A
ASP
36
-91.74
54.71
2
A
PRO
47
-71.35
-156.78
2
A
ASP
51
-164.30
112.46
2
A
PRO
54
-74.80
-84.08
2
A
GLU
57
-101.75
-123.50
2
A
CYS
58
-114.39
-70.31
2
A
GLU
59
-95.36
-110.25
2
B
ALA
2
-127.75
-152.25
2
B
PHE
19
-45.02
166.71
2
B
ASP
36
-96.81
46.16
2
B
PRO
54
-70.01
-135.77
2
B
GLU
55
-150.32
-43.11
2
B
GLU
56
-121.70
-69.76
2
B
CYS
58
-83.23
43.62
2
B
GLU
59
-160.30
111.63
3
A
ALA
2
-107.68
70.76
3
A
ASN
16
-27.63
150.37
3
A
VAL
22
-31.56
154.68
3
A
ASP
36
-89.62
38.02
3
A
VAL
52
-156.71
30.51
3
A
GLU
55
-93.14
-157.41
3
A
GLU
56
-165.50
-20.18
3
A
GLU
59
-145.08
16.66
3
B
ALA
2
-96.62
37.24
3
B
THR
8
-97.77
55.73
3
B
ASN
16
-33.80
150.03
3
B
VAL
22
-47.94
158.83
3
B
ASP
36
-94.78
46.79
3
B
PRO
47
-69.95
-172.42
3
B
THR
49
-67.66
80.54
3
B
GLU
57
-114.97
60.81
3
B
CYS
58
-165.57
32.24
4
A
THR
8
-100.30
63.58
4
A
ASN
16
-23.48
150.02
4
A
VAL
22
-31.58
156.23
4
A
ASP
36
-96.68
32.54
4
A
GLU
55
-98.51
49.55
4
A
CYS
58
-144.49
-4.20
4
A
GLU
59
-81.82
-72.70
4
B
ALA
2
-73.45
-129.39
4
B
ASN
16
-30.01
133.67
4
B
PHE
19
-44.83
172.86
4
B
VAL
52
-158.46
76.00
4
B
PRO
54
-69.57
88.87
4
B
GLU
55
-104.56
-119.56
4
B
GLU
57
-125.35
-121.20
4
B
CYS
58
-123.72
-78.80
5
A
ALA
2
-164.13
79.14
5
A
THR
8
-69.96
92.14
5
A
GLU
13
-109.77
45.60
5
A
ASN
16
-23.02
147.06
5
A
ASP
35
-159.79
79.94
5
A
ASP
36
-80.46
46.00
5
A
PHE
45
-124.70
-169.95
5
A
PRO
47
-71.17
-158.13
5
A
ASN
48
-163.03
102.48
5
A
GLU
57
-144.20
-0.61
5
A
CYS
58
-72.33
22.09
5
B
THR
4
-68.73
-162.47
5
B
PRO
11
-39.69
-34.45
5
B
ASN
16
-34.36
139.76
5
B
VAL
22
-27.70
139.83
5
B
GLU
59
-162.06
-46.59
6
A
ALA
2
-151.75
30.58
6
A
ASN
16
-22.51
148.45
6
A
VAL
22
-24.93
150.83
6
A
THR
37
-48.71
-7.44
6
A
ARG
39
-69.27
-165.50
6
A
ASP
51
-161.97
-169.51
6
A
GLU
56
-70.77
33.44
6
A
CYS
58
-98.99
-106.93
6
A
GLU
59
-141.77
-145.78
6
B
ASN
16
-32.95
150.06
6
B
GLN
26
-39.34
-34.45
6
B
ASP
36
-91.83
51.53
6
B
ARG
39
-67.98
-178.17
6
B
PRO
47
-72.32
-169.87
6
B
GLU
55
-95.59
-98.00
6
B
GLU
57
-123.47
-120.39
6
B
GLU
59
-169.98
-18.10
7
A
ASN
16
-35.29
122.02
7
A
PHE
19
-44.78
167.87
7
A
VAL
22
-49.93
171.03
7
A
PHE
45
-122.71
-169.93
7
A
PRO
47
-70.87
-156.53
7
A
VAL
52
-159.43
67.75
7
A
GLU
55
-134.43
-81.01
7
B
THR
4
-117.24
-159.92
7
B
ASN
16
-24.36
138.13
7
B
VAL
22
-49.66
161.20
7
B
TYR
46
-46.81
150.57
7
B
GLU
55
-124.73
-164.99
7
B
GLU
59
-152.01
-33.88
8
A
GLU
5
-61.50
-174.92
8
A
PRO
11
-46.92
-74.61
8
A
GLU
13
-89.66
35.71
8
A
ASN
16
-30.31
150.31
8
A
VAL
22
-26.21
152.84
8
A
ASP
36
-78.18
21.54
8
A
PRO
47
-61.02
-150.74
8
A
GLU
56
-163.44
-2.62
8
A
GLU
57
-141.23
-136.61
8
A
CYS
58
-94.50
-70.56
8
A
GLU
59
-143.67
14.11
8
B
ASN
16
-32.64
140.07
8
B
GLN
26
-50.04
-72.85
8
B
PRO
54
-70.35
-84.06
8
B
GLU
55
-165.34
-167.21
8
B
GLU
56
-102.79
-141.19
9
A
CYS
7
-146.50
19.38
9
A
THR
8
-100.22
63.16
9
A
ASN
16
-24.92
150.08
9
A
PRO
47
-73.35
-156.70
9
A
GLU
55
-132.32
-38.33
9
A
GLU
56
-97.35
-75.34
9
A
GLU
59
-84.45
-87.45
9
B
PRO
47
-69.40
-170.58
9
B
PRO
54
-70.09
-110.67
9
B
GLU
55
-164.22
-152.37
9
B
GLU
57
-143.47
-14.18
9
B
CYS
58
-88.75
-137.54
10
A
THR
4
-170.44
-159.91
10
A
CYS
7
-143.19
-2.30
10
A
ASN
16
-27.70
150.32
10
A
VAL
22
-30.34
155.04
10
A
ASP
35
-155.72
79.84
10
A
ASP
36
-88.18
40.50
10
A
PRO
47
-80.85
-156.53
10
A
PRO
54
-71.01
-121.62
10
A
GLU
55
-151.61
-138.19
10
B
ARG
14
-63.29
94.98
10
B
ASN
16
-23.61
149.76
10
B
VAL
22
-37.86
153.06
10
B
PRO
47
-62.80
-173.48
10
B
VAL
52
-155.21
23.88
10
B
GLU
55
-119.98
-164.42
10
B
GLU
56
-94.73
-139.77
10
B
GLU
59
-105.15
-71.50
PS2 PROTEIN
NMR SOLUTION STRUCTURE OF THE DISULPHIDE-LINKED HOMODIMER OF HUMAN TFF1, 10 STRUCTURES
1
N
N
1
N
N
A
THR
23
A
THR
23
HELX_P
A
LYS
30
A
LYS
30
1
1
8
B
THR
23
B
THR
23
HELX_P
B
LYS
30
B
LYS
30
1
2
8
disulf
2.028
A
CYS
7
A
SG
CYS
7
1_555
A
CYS
33
A
SG
CYS
33
1_555
disulf
2.031
A
CYS
17
A
SG
CYS
17
1_555
A
CYS
32
A
SG
CYS
32
1_555
disulf
2.030
A
CYS
27
A
SG
CYS
27
1_555
A
CYS
44
A
SG
CYS
44
1_555
disulf
2.030
A
CYS
58
A
SG
CYS
58
1_555
B
CYS
58
B
SG
CYS
58
1_555
disulf
2.029
B
CYS
7
B
SG
CYS
7
1_555
B
CYS
33
B
SG
CYS
33
1_555
disulf
2.028
B
CYS
17
B
SG
CYS
17
1_555
B
CYS
32
B
SG
CYS
32
1_555
disulf
2.030
B
CYS
27
B
SG
CYS
27
1_555
B
CYS
44
B
SG
CYS
44
1_555
GROWTH FACTOR
GROWTH FACTOR, CELL MOTILITY, TUMOR SUPPRESSOR, TREFOIL DOMAIN
PS2_HUMAN
UNP
1
P04155
25
84
1HI7
1
60
P04155
A
1
1
60
25
84
1HI7
1
60
P04155
B
1
1
60
2
2
2
2
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
THR
4
A
THR
4
A
THR
6
A
THR
6
A
ASN
48
A
ASN
48
A
ILE
50
A
ILE
50
A
CYS
33
A
CYS
33
A
PHE
34
A
PHE
34
A
CYS
44
A
CYS
44
A
PHE
45
A
PHE
45
B
THR
4
B
THR
4
B
THR
6
B
THR
6
B
ASN
48
B
ASN
48
B
ILE
50
B
ILE
50
B
CYS
33
B
CYS
33
B
PHE
34
B
PHE
34
B
CYS
44
B
CYS
44
B
PHE
45
B
PHE
45
1
P 1